In Vitro Diagnostics (IVD)
ChallengesOffering IVDs in the European Union (EU) requires compliance with the In-Vitro Diagnostic Directive (IVDD; directive 98/79/EC), which lists devices that require specific assessments into two categories: List A (e.g., blood grouping, HIV screening) and List B (e.g., HLA grouping; detection of Chlamydia, rubella; monitoring blood glucose). LNE/GMED has the necessary expertise with In Vitro Medical Devices to perform a thorough, relevant assessment based on your products' IVD status. IVD Manufacturers: Avoid pitfalls that can delay or derail CE Marking AdvantagesLNE/G-MED is recognized to assess Active Implantable Medical Devices and has significant experience certifying a wide range of devices for CE Marking, often in conjunction with ISO 13485, CMDCAS, third party FDA inspection and other certificates, to save the time and cost of multiple audits. You also benefit from:
Find Out MoreLNE/G-MED America offers in-person, online and other customized training on a wide range of certification and quality topics. For details, check out our training schedule or request a customized program.
*Source: Richard Park, The Year in IVDs, IVD Technology, October 2009: online |





- Progress Report - News
- EC Publishes E-Labeling Regulation
- IVD Updates
- Post-Market Phase
- IEC 60601 3rd Edition
- Tech File Evaluation
- Clinical Evaluation
- Recast of IVD Directive
- Own Brand Label Devices
- Software Engineering
- Med. Device Packaging
- Single Use Devices
- Usability Engineering
- FDA Use of ISO 13485
- Risk Management
- IVD Directive
- Switching Notified Body
- Regulatory News
- Ask Our Experts
- Free Guide: CE Marking
- Free Guide: IEC 60601 3rd Edition
- Free Guide: EMC Testing
- Free Guide: IVD
- Free Guide: Brazil MD Approval
- Technical FAQs
- Progress Report - News



Manufacturers continue to develop and release faster, more accurate 
